Diffuse Midline Glioma, H3 K27M-Mutant

Also known as: Diffuse midline glioma H3K27M mutation / Glioma, Diffuse Midline, H3K27M-mutant / Glioma of brainstem (disorder) / Brain stem glioma / Diffuse midline glioma, point mutation K27M in histone H3 (morphologic abnormality)

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB11740	Adavosertib	1	Completed	1
DB15676	Balstilimab	1	Recruiting	1
DB00531	Cyclophosphamide	1	Recruiting	1
DB00773	Etoposide	1	Active Not Recruiting	1
DB00099	Filgrastim	1	Completed	1
DB01073	Fludarabine	1	Recruiting	1
DB00441	Gemcitabine	1	Completed	1
DB00724	Imiquimod	1	Recruiting	1
DB06603	Panobinostat	1	Active Not Recruiting	1
DB15289	Perillyl alcohol	1	Not Yet Recruiting	1
DB11730	Ribociclib	1	Completed	1
DB17380	Saposin C	1	Recruiting	1
DB09143	Sonidegib	1	Completed	1
DB08911	Trametinib	1	Completed	1
DB15632	Zalifrelimab	1	Recruiting	1
DB01175	Escitalopram	1 / 2	Recruiting	1
DB09035	Nivolumab	1 / 2	Completed	1
DB00129	Ornithine	1 / 2	Recruiting	1
DB11942	Selinexor	1 / 2	Recruiting	1
DB00988	Dopamine	2	Recruiting	1
DB14844	Dordaviprone	2	Recruiting	1
DB01590	Everolimus	2	Not Yet Recruiting	1
DB16267	Olutasidenib	2	Not Yet Recruiting	1
DB11066	Pancrelipase protease	2	Recruiting	1
DB15186	Paxalisib	2	Recruiting	1
DB11730	Ribociclib	2	Not Yet Recruiting	1
DB00853	Temozolomide	2	Not Yet Recruiting	1
DB14844	Dordaviprone	3	Recruiting	1
DB01590	Everolimus	3	Recruiting	1
DB17298	Disufenton	Not Available	Available	1